H1 2025 EBITDA was DKK 13.9 billion, up 9% year-on-year excluding partnerships and cancellation fees, while offshore site earnings rose to DKK 12.5 billion. An extraordinary general meeting will be ...

On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at ...

Board of Directors has approved the interim report for the first half of 2025, with Rasmus Errboe, Group President and ...

DJ Operations well above last year and delivering strong H1 2025 results Ørsted A/S (Orsted) Operations well above last year and delivering strong H1 2025 results 11-Aug-2025 / 07:31 CET/CEST =------- ...

DJ Ørsted announces plan for a rights issue with support from the Danish State as majority shareholder and gross proceeds of DKK 60 billion Ørsted A/S (Orsted) Ørsted announces plan for a rights issue ...

Novo Nordisk's steep stock decline has pushed it into deep undervaluation, now trading at attractive multiples below ...

Novo Nordisk remains the GLP-1 leader with over 65% market share. Read an in-depth BVO stock analysis and why we rate it as a ...

Lundin Gold Inc. was the biggest leader among large stocks during the session, surging 10.8%, and Tomra Systems ASA increased 8.5%. Novo Nordisk A/S rounded out the top three leaders on Friday, with ...

Novo Nordisk has been losing big in the past year and is down over 66% from its peak in 2024. On the other hand, Eli Lilly ...

Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 ...

AP Moller-Maersk shares rose after it reported strong earnings for the second quarter.

Novo Nordisk A/S (NYSE:NVO) is one of the top NYSE stocks with the highest upside potential. On August 5, UBS downgraded Novo ...